Dysregulated calcium underlies hyposalivation and microbial dysbiosis in Down syndrome
Ontology highlight
ABSTRACT: Oral diseases have a lifelong impact on human health and quality of life. Down syndrome (DS) individuals contend with decreased saliva production and periodontal disease for unknown reasons. We investigated the molecular mechanisms of hyposalivation in a DS mouse model (Dp16 mice) and identified decreased Ca2+ uptake in salivary glands essential for saliva fluid secretion. Human iPSC from DS individuals also showed decreased Ca2+ uptake. Decreased saliva in Dp16 mice altered the oral and gut microbiome enriched in succinate-associate microbes. Metabolomic analysis confirmed elevated succinate levels, a signaling molecule linked to periodontal disease. Because Ca2+ dysregulation and hyposalivation are features of Sjogren’s disease, we addressed if DS individuals might be at greater risk of developing Sjogren’s by treating Dp16 mice with DMXAA. Treated Dp16 mice exhibited signs of Sjogren’s. Using the therapeutic agent pilocarpine prescribed in the management of Sjogren’s we enhanced salivation and decreased inflammation.
ORGANISM(S): Mus musculus
PROVIDER: GSE331212 | GEO | 2026/05/29
REPOSITORIES: GEO
ACCESS DATA